Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Apellis Pharmaceuticals buy BiotechBee

Start price
€69.48
29.09.22 / 50%
Target price
€80.00
31.12.24
Performance (%)
17.30%
End price
€81.50
05.05.23
Summary
This prediction ended on 05.05.23 with a price of €81.50. The BUY prediction by BiotechBee finished with a performance of 17.30%. BiotechBee has a follow-up prediction for Apellis Pharmaceuticals where he still thinks Apellis Pharmaceuticals is a Buy. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Apellis Pharmaceuticals - - -
iShares Core DAX® 1.883% 5.122% 21.667%
iShares Nasdaq 100 0.125% 2.574% 45.951%
iShares Nikkei 225® -0.201% 4.341% 28.806%
iShares S&P 500 0.728% 4.141% 34.630%

According to BiotechBee what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Apellis Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 17.30%
Target price 80.000
Change
Ends at 31.12.24

Buy mit Kursziel 80,0

In the thread Trading Apellis Pharmaceuticals
Prediction Sell
Perf. (%) 17.30%
Target price 80.000
Change
Ends at 31.12.24

Buy beendet

Current prediction by BiotechBee for Apellis Pharmaceuticals

buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€41.00
17.09.23
€60.00
30.09.25
32.93%
28.03.24

Could be very worthwhile Investment >20% year

Stopped prediction by BiotechBee for Apellis Pharmaceuticals

buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€37.00
30.07.23
€50.00
31.01.26
10.81%
17.09.23

Could be very worthwhile Investment >20% year
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€50.50
17.07.23
€90.00
31.03.26
18.81%
17.07.23

Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€64.19
07.09.22
€35.00
31.12.24
8.24%
29.09.22

Could be very worthwhile Investment >20% year